Have a personal or library account? Click to login
The functional role of miRNAs in inflammatory pathways associated with intestinal epithelial tight junction barrier regulation in IBD Cover

The functional role of miRNAs in inflammatory pathways associated with intestinal epithelial tight junction barrier regulation in IBD

Open Access
|Jun 2022

Figures & Tables

Fig. 1

Mechanism of action of miRNA-based drugs in IBD. The left side demonstrates the molecular effect of altered miRNAs’ expression in IBD. The right side shows miRNA-based treatment response. miRNA–microRNA; TJs–tight junctions; IEB–intestinal epithelial barrier
Mechanism of action of miRNA-based drugs in IBD. The left side demonstrates the molecular effect of altered miRNAs’ expression in IBD. The right side shows miRNA-based treatment response. miRNA–microRNA; TJs–tight junctions; IEB–intestinal epithelial barrier

MiRNAs collected in this review with their targets, marked expression in IBD, and altered TJ proteins expression_ The table was divided into in vivo and in vitro examined effects on TJ proteins expression induced by altered miRNA expression; miRNA–microRNA; ZO-1–Zonula occludens-1; CLDN–Claudin; JAM-A–junctional adhesion molecules A; AJ–adherent junction; CD–-Crohn's disease; UC–-ulcerative colitis; IBD–inflammatory bowel disease; PBMCs–peripheral blood mononuclear cells

microRNATarget mRNAExpression in IBDTJ proteins expression associated with miRNA-induced effectAuthor/year
In vivo observed effects
miRNA-124aAryl hydrocarbon receptor (AhR)Overexpression in CD tissueZO-1 ↓, OCLN ↓, JAM-A ↓, CLDN1 ↓Zhao et al., 2020 [58]
miRNA-31-5pActivin receptor-like type 1 (ALK1)Overexpression in CD tissueCLDN8 ↓, TJP1 ↓, OCLN ↓Toyonaga et al., 2020 [39]
miRNA-301AB-cell translocation gene 1 (BTG1)Overexpression in PBMCs and tissue in IBDE-cadherin (AJ) ↓He et al., 2017 [86]
miRNA-200bMyosin light chain kinase (MLCK) and c-JUNDecreased in IBD tissueZO-1 ↓, OCLN ↓Shen et al., 2017 [64]
miRNA-21Claudin 8 (CLDN8)Overexpression in CD tissueCLDN8 ↓Li et al., 2018 [71]
miRNA-200c-3pOccludin (OCLN)Overexpression in UC tissueOCLN ↓Rawat et al., 2020 [81]
miRNA-495Signal transducer and activator of transcription 3 (STAT3)Decreased in UC tissueCLDN1 ↓Chu et al., 2018 [90]
miRNA-122aEpidermal growth factor receptor (EGFR)Overexpression in IBD tissueCLDN1 ↓, OCLN ↓, Zonulin ↑Zhang et al., 2017 [92]
miRNA-320aProtein phosphatase 2 (PP2A) and Cell division cycle 42 (Cdc42)Overexpression in serum of active CDJAM-A ↑Cordes et al., 2016 [106]
miRNA-423-5pCLDN5Overexpression in UC tissueCLDN5 ↓Wang et al., 2020 [77]
In vitro observed effects
miRNA-185-3pMyosin light chain kinase (MLCK)Decreased in IBD tissueZO-1 ↓, OCLN ↓Ma et al., 2019 [63]
miRNA-23aTumor necrosis factor alpha inhibitor protein 3 (TNFAIP3)Overexpression in CD tissueOCLN destabilizationFelwick et al., 2020 [33]
miRNA-675-5pVitamin D receptor (VDR)Overexpression in UC tissueZO-1 ↓, OCLN ↓Chen et al., 2016 [52]
miRNA-375Toll-like receptor 4 (TLR4)Decreased in IBD tissueZO-1 ↓, OCLN ↓Wu et al., 2019 [98]
miRNA-223Claudin 8 (CLDN8)Overexpression in IBD tissueCLDN8 ↓Wang et al., 2016 [68]
Language: English
Page range: 254 - 267
Submitted on: Aug 18, 2021
Accepted on: Dec 28, 2021
Published on: Jun 29, 2022
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Błażej Ochman, Agnieszka Kula, Elżbieta Świętochowska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.